Details of the Drug
General Information of Drug (ID: DMSPVXM)
| Drug Name |
5-Propyl-1H-pyrazole-3-carboxylic acid
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
3-propyl-1H-pyrazole-5-carboxylic acid; 76424-47-0; 5-Propyl-1H-pyrazole-3-carboxylic acid; 5-Propyl-2H-pyrazole-3-carboxylic acid; CHEMBL237788; 3-n-propyl-1H-pyrazole-5-carboxylic acid; AC1LDWNQ; BAS 01543590; SCHEMBL1092; AC1Q2V2W; Oprea1_206890; ZINC39600; CTK6D4610; KS-00003OFY; CTK2H6772; DTXSID20350296; MolPort-001-965-385; QYPSYPPSHXDFLV-UHFFFAOYSA-N; MolPort-000-929-573; HMS1697E16; 3-propylpyrazole-5-carboxylic acid; BDBM50220850; BBL031087; STL244838; KM1764; 9410AE; AKOS000136076; AKOS000646963; MS-2036; MCULE-2411097064
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 154.17 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 1.3 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


